Hygiena 2007, 52(2):36-42
Smoking Attributable Hospital Treatment in the Czech Republic in 2002 and Estimate of Treatment Costs
- Státní zdravotní ústav, Praha
OBJECTIVES: To estimate smoking-attributable hospitalizations and to quantify costs of hospital treatment in the Czech Republic in 2002 based on data from the General Health Insurance Company (GHIC).
METHOD: For computation of smoking-attributable fractions we used data from the US Cancer Prevention Study II and smoking prevalence from a large national population survey carried out in 2002. Gender and disease specific data on hospitalizations and cost of treatment were provided by the GHIC.
RESULTS: In 2002 there were in sum 145,336 smoking attributable hospitalizations. Of that, the most prevalent were hospitalizations for cardiovascular diseases (97,961). Among malignant neoplasms there were 12,465 hospitalizations due to lung cancer (51 % of all hospitalizations for smoking attributable malignant neoplasms). Hospitalizations for lung cancer were more frequent in males compared to females (the M:F ratio was 3.6:1). Total costs of hospital treatment of smoking attributable diseases represented 4.7 billion CZK, which is about 11 % of total costs for hospital care of the GHIC.
CONCLUSIONS: Rates of morbidity caused by smoking suggest that the importance of smoking as a risk factor for national health is very high. Treatment costs represent a serious economic burden. Effective strategy to reduce health-related and economic harm caused by smoking, is a combination of restrictive measures focused on availability of tobacco products with health promoting programmes and smoking cessation programmes.
Keywords: tobacco smoking, morbidity, hospitalizations, cost of treatment, Czech Republic
Published: June 2007 Show citation
References
- Banegas JR, Diez Ganan L, Gonzalez Enriquez J, Villar Alvarez F, Rodriguez-Artalejo F. Recent decrease in smoking-attributable mortality in Spain. Med Clin. 2005 May 28;124(20):769-71. (In Spanish.) Go to original source... Go to PubMed...
- Banegas JR, Rodriguez-Artalejo F, Graciani A, Villar F, Herruzo R. Mortality attributable to cardiovascular risk factors in Spain. Eur J Clin Nutr. 2003 Sep;57 Suppl 1:S18-S21. Go to original source... Go to PubMed...
- Bloomfield K, et al. Gender, culture and alcohol problems: a multi-national study [project final report]. Berlin: Institute for Medical Informatics, Biometrics and Epidemiology, Charité Universitätsmedizin Berlin; 2005.
- Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002 Apr 12;51(14):300-3.
- Smoking-attributable mortality and years of potential life lost - United States, 1984. MMWR Morb Mortal Wkly Rep. 1997 May 23;46(20):444-51.
- Centers for Disease Control and Prevention. 2002. Smoking-attributable mortality, morbidity, and economic costs (SAMMEC): adult SAMMEC and maternal and child health (MCH) SAMMEC software [homepage on the Internet]. Atlanta(CA): CDC. [cited 2007 Apr 17]. Available from: http://www.cdc.gov/tobacco/sammec.htm.
- Cífková R, Škodová Z. Dlouhodobé trendy hlavních rizikových faktorů kardiovaskulárních onemocnění v české populaci. Cas Lek Ces. 2004;143(4):219-26.
- Kollarová H, Janout V, Čížek L. Epidemiology of lung cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002 Dec;146(2):103-14. Go to original source... Go to PubMed...
- Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer. 2005 Oct 10;116(6):963-71. Go to original source... Go to PubMed...
- Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003 Sep 13;362(9387):847-52. Go to original source... Go to PubMed...
- Gorini G, Chellini E, Querci A, Seniori Costantini A. Impact of smoking in Italy in 1998: deaths and years of potential life lost. Epidemiol Prev. 2003 Sep-Oct;27(5):285-90. (In Italian.) Go to PubMed...
- Jarmozik K. Tobacco and cardiovascular disease. In: Boyle P, Gray N, Henningfeld J, Seffrin J, Zatonski W, editors. Tobacco: science, policy and public health. New York: Oxford University Press; 2005. p 549-76.
- Karimian-Teherani D, Vutuc C, Janout V. Mortality trends of lung cancer in Austria and the Czech Republic. Neoplasma. 2001;48(4):257-61. Go to PubMed...
- Kříž J, editor. Zdravotní stav populace. Jak jsme na tom se zdravím? Praha: Státní zdravotní ústav; 2004.
- Kubík AK, Zatloukal P, Tomášek L, Petruželka L. Lung cancer risk among Czech women: a case-control study. Prev Med. 2002 Apr;34(4):436-44. Go to original source... Go to PubMed...
- Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from smoking in developed countries 1950-2000. 2nd ed. Oxford: Oxford University Press; 2003.
- Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992 May 23;339(8804):1268-78. Go to original source...
- Sharp L, Brewster D. The epidemiology of lung cancer in Scotland: a review of trends in incidence, survival and mortality and prospects for prevention. Health Bull. 1999 Sep;57(5): 318-31. 2006;86(1):100-4.
- Sovinová H, Csémy L, editoři. Kouření cigaret a pití alkoholu v České republice. Praha: Státní zdravotní ústav; 2003.
- Sovinová H, Csémy L. The changing smoking and health scene in the Czech Republic. Nutrition. 2000 Nov-Dec;16(11-12): 1112-3. Go to original source... Go to PubMed...
- Thun MJ, Day-Lally C, Myers DG, Calle EE, Flanders DW, Zhu BP, et al. Trends in tobacco smoking and mortality from cigarette use in Cancer Prevention Studies I (1959 through 1965) and II (1982 through 1988). In: Smoking and tobacco control monograph 8: changes in cigarette-related disease risks and their implications for prevention and control. Bethesda: Cancer Institute; 1997. p. 305-82.
- Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004 Mar 9;109(9):1101-7. Go to original source... Go to PubMed...
- Velkova A, Wolleswinkel-van den Bosch JH, Mackenbach JP. The East-West life expectancy gap: differences in mortality from conditions amenable to medical intervention. Int J Epidemiol. 1997 Feb;26(1):75-84. Go to original source...
- WHO. The world health report 2002. Reducing risks, promoting healthy life. Geneva: WHO; 2002.